July 16, 2024
Family-owned micro-nutrient supplements manufacturer and brand owner Orthomol is preparing for a sale advised by Houlihan Lokey with projected 2024 adj. EBITDA of EUR 55m, according to sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights